130 related articles for article (PubMed ID: 36417979)
1. Clinical risk factors for vasculo-placental disorders: results from a prospective case-control study nested in HEMOTHEPP French cohort study.
de Moreuil C; Pan-Petesch B; Trémouilhac C; Dupré PF; Merviel P; Anouilh F; Bellot C; Müller M; Drugmanne G; Nowak E; Coadic J; Bihan L; Gourhant L; Lemarié C; Robin S; Couturaud F; Moigne EL
J Gynecol Obstet Hum Reprod; 2023 Jan; 52(1):102511. PubMed ID: 36417979
[TBL] [Abstract][Full Text] [Related]
2. Preconception venous thromboembolism and placenta-mediated pregnancy complications.
Hansen AT; Schmidt M; Horváth-Puhó E; Pedersen L; Rothman KJ; Hvas AM; Sørensen HT
J Thromb Haemost; 2015 Sep; 13(9):1635-41. PubMed ID: 26178661
[TBL] [Abstract][Full Text] [Related]
3. Influence of hypertensive disorders and cigarette smoking on placental abruption and uterine bleeding during pregnancy.
Ananth CV; Savitz DA; Bowes WA; Luther ER
Br J Obstet Gynaecol; 1997 May; 104(5):572-8. PubMed ID: 9166200
[TBL] [Abstract][Full Text] [Related]
4. Placental volume, vasculature and calcification in pregnancies complicated by pre-eclampsia and intra-uterine growth restriction.
Moran MC; Mulcahy C; Zombori G; Ryan J; Downey P; McAuliffe FM
Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():12-17. PubMed ID: 26461962
[TBL] [Abstract][Full Text] [Related]
5. Identifying risk factors for placental abruption in subsequent pregnancy without a history of placental abruption.
Goldbart A; Pariente G; Sheiner E; Wainstock T
Int J Gynaecol Obstet; 2023 May; 161(2):406-411. PubMed ID: 36083780
[TBL] [Abstract][Full Text] [Related]
6. The comparison of placental abruption coupled with and without preeclampsia and/or intrauterine growth restriction in singleton pregnancies.
Ni S; Wang X; Cheng X
J Matern Fetal Neonatal Med; 2021 May; 34(9):1395-1400. PubMed ID: 31248311
[TBL] [Abstract][Full Text] [Related]
7. Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A.
Proctor LK; Toal M; Keating S; Chitayat D; Okun N; Windrim RC; Smith GC; Kingdom JC
Ultrasound Obstet Gynecol; 2009 Sep; 34(3):274-82. PubMed ID: 19672838
[TBL] [Abstract][Full Text] [Related]
8. Placental abruption and adverse perinatal outcomes.
Ananth CV; Berkowitz GS; Savitz DA; Lapinski RH
JAMA; 1999 Nov; 282(17):1646-51. PubMed ID: 10553791
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with poor fetal outcome in placental abruption.
de Moreuil C; Hannigsberg J; Chauvet J; Remoue A; Tremouilhac C; Merviel P; Bellot C; Pan Petesch B; Le Moigne E; Lacut K; Marcorelles P
Pregnancy Hypertens; 2021 Mar; 23():59-65. PubMed ID: 33264704
[TBL] [Abstract][Full Text] [Related]
10. Term complications and subsequent risk of preterm birth: registry based study.
Kvalvik LG; Wilcox AJ; Skjærven R; Østbye T; Harmon QE
BMJ; 2020 Apr; 369():m1007. PubMed ID: 32349968
[TBL] [Abstract][Full Text] [Related]
11. Pravastatin is useful for prevention of recurrent severe placenta-mediated complications - a pilot study.
Kupferminc MJ; Kliger C; Rimon E; Asher-Landsberg J; Skornick-Rapaport A; Gamzu R; Yogev Y
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8055-8061. PubMed ID: 34154497
[TBL] [Abstract][Full Text] [Related]
12. The ability of late pregnancy maternal tests to predict adverse pregnancy outcomes associated with placental dysfunction (specifically fetal growth restriction and pre-eclampsia): a protocol for a systematic review and meta-analysis of prognostic accuracy studies.
Griffin M; Heazell AEP; Chappell LC; Zhao J; Lawlor DA
Syst Rev; 2020 Apr; 9(1):78. PubMed ID: 32268905
[TBL] [Abstract][Full Text] [Related]
13. Placenta associated pregnancy complications in pregnancies complicated with placenta previa.
Baumfeld Y; Herskovitz R; Niv ZB; Mastrolia SA; Weintraub AY
Taiwan J Obstet Gynecol; 2017 Jun; 56(3):331-335. PubMed ID: 28600043
[TBL] [Abstract][Full Text] [Related]
14. The pre-eclampsia, growth restriction, and ductus venosus doppler (GRADED) study: An observational study of early-onset fetal growth restriction and pre-eclampsia.
Govender V; Naidoo TD; Foolchand S
Int J Gynaecol Obstet; 2023 Apr; 161(1):106-113. PubMed ID: 36200937
[TBL] [Abstract][Full Text] [Related]
15. Placental abruption and subsequent risk of pre-eclampsia: a population-based case-control study.
Parker SE; Werler MM; Gissler M; Tikkanen M; Ananth CV
Paediatr Perinat Epidemiol; 2015 May; 29(3):211-9. PubMed ID: 25761509
[TBL] [Abstract][Full Text] [Related]
16. Screening for placental insufficiency in high-risk pregnancies: is earlier better?
Costa SL; Proctor L; Dodd JM; Toal M; Okun N; Johnson JA; Windrim R; Kingdom JC
Placenta; 2008 Dec; 29(12):1034-40. PubMed ID: 18930542
[TBL] [Abstract][Full Text] [Related]
17. Hyperemesis gravidarum and risks of placental dysfunction disorders: a population-based cohort study.
Bolin M; Åkerud H; Cnattingius S; Stephansson O; Wikström AK
BJOG; 2013 Apr; 120(5):541-7. PubMed ID: 23360164
[TBL] [Abstract][Full Text] [Related]
18. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery.
Lyall F; Young A; Boswell F; Kingdom JC; Greer IA
Placenta; 1997 May; 18(4):269-76. PubMed ID: 9179920
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of fetal growth restriction: implications for diagnosis and surveillance.
Baschat AA
Obstet Gynecol Surv; 2004 Aug; 59(8):617-27. PubMed ID: 15277896
[TBL] [Abstract][Full Text] [Related]
20. Inherited thrombophilias and adverse pregnancy outcomes: a case-control study in an Australian population.
Said JM; Higgins JR; Moses EK; Walker SP; Monagle PT; Brennecke SP
Acta Obstet Gynecol Scand; 2012 Feb; 91(2):250-5. PubMed ID: 21985600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
